Almost immediately after the Phase 3 results came out, I think this board (as well as the Investor Village board) has been beset with assumptions that the Crestor group worked, but not the Lipitor.  

I think that is not supported by what we know so far.  If Lipitor did not work as people are assuming (and half the dosed patients were on Lipitor), then there is no way that DM and Dr. Wong can claim the data is so great.  If half the dosed patient group did not respond to Apabetalone, then it is impossible that the secondary end points are met.

I am going with DM's insistence that we only need to wait till Nov 16 to see the wonderful data.  That means I don't buy this belief that only the Crestor leg worked...both have to work for Apabetalone to have any shot at FDA acceptance.